$2.860
-0.569 (-19.89%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CRBP por análisis de gráficos similares
Alphio's CRBP stock price prediction model matches the current Corbus Pharmaceuticals Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.08 (+0.17%). The 1-week path is $3.07 (-0.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Corbus Pharmaceuticals Holdings Inc?
Corbus Pharmaceuticals is not a good buy right now. The current price is $3.915, which is significantly lower than the 52-week high of $12.88, indicating a downtrend. The RSI is at 21.889, suggesting that the stock is oversold, but this could also indicate continued weakness. Furthermore, the company has reported substantial losses, with a net income of -$35,037,000 in Q2 2026, and a forward P/E ratio of 0, indicating no earnings expected in the near term. The main risk is the high volatility, as indicated by an implied volatility of 327.95% and a historical volatility of 55.29%.
CRBP cerró en $2.86 el Thursday, tras bajar -19.89%
Corbus Pharmaceuticals Holdings Inc (CRBP) last closed at $3.0699999, gaining +7.34%. These facts feed the 1-day and 1-week CRBP price prediction above.
Consenso de analistas
Corbus Pharmaceuticals Holdings Inc (CRBP): 3 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Corbus Pharmaceuticals Holdings Inc (CRBP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CRBP, ordenadas por similitud.
Análisis de estacionalidad de CRBP
Historically the probability of a positive November return for CRBP is 47.73%. October offers the highest probability of a positive month at 67.65%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CRBP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $6.18 | $7.70 | $8.45 | +150.88% |
| Dec 2026 | $7.74 | $8.95 | $10.05 | +191.69% |
En 2026, se proyecta que Corbus Pharmaceuticals Holdings Inc (CRBP) oscile entre $6.18 y $10.05.
Previsión mensual de Corbus Pharmaceuticals Holdings Inc para 2026
En Nov de 2026, se proyecta que Corbus Pharmaceuticals Holdings Inc promedie $7.70, con un mínimo de $6.18 y un máximo de $8.45.
En Dec de 2026, se proyecta que Corbus Pharmaceuticals Holdings Inc promedie $8.95, con un mínimo de $7.74 y un máximo de $10.05.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.